Profile cover photo
Profile photo
Scimega Oncology
36 followers -
Experts in Clinical Oncology
Experts in Clinical Oncology

36 followers
About
Posts

Post is pinned.Post has attachment
Get answers to some important questions that are having a big impact on improving oncology clinical trial performance in Canada. See the latest oncology clinical trial performance from Canada's Reverse Feasibility Champions. The results are impressive!
Add a comment...

Post has attachment
Matching investigator needs with sponsor protocols to accelerate study start-up times and bolster patient recruitment.
Add a comment...

Post has attachment
Hear what's new about the regulatory submission process in Canada, why cutting-edge science and a well-designed protocol are not enough, and how to help sites overcome the hurdles of participating in clinical trials.
Add a comment...

Post has attachment
Roberto Lara to present on April 6th in Burlingame, CA.
Hear what's new about the regulatory submission process in Canada, why cutting-edge science and a well-designed protocol are not enough, and how to help sites overcome the hurdles of participating in clinical trials.
Add a comment...

Post has attachment
Join us at ASH to learn how Scimega's model Clinical Trial Agreement process alleviates the administrative burden and removes contract signing bottlenecks, leading to faster FSO and First-Patient-In.
Photo
Add a comment...

Post has attachment

Post has attachment
Meet us in Boston from Nov 4th - 7th at the #AACR conference to see how a #targeted and #personalized approach to site selection can solve your biggest patient recruitment hurdles. The results from the #ReverseFeasibilityProgram below speak  for themselves.
Molecular Targets & Cancer Therapeutics
Molecular Targets & Cancer Therapeutics
campaign.r20.constantcontact.com
Add a comment...

Post has attachment
Roberto Lara is speaking at the MAGI Clinical Research Conference, Oct 11th & 12th in San Diego. He's an expert panelist for an advanced, interactive session designed for clinical research professionals dealing with the complex challenges particular to oncology.

He is also presenting on Day 2 on the topic of Preferred Site Alliances for Long-Term Relationships.
Add a comment...

Post has attachment
You'll never guess what this cancer patient did. Check out this story to see just how important clinical trials are and what we are doing to continually improve clinical trial performance.
Add a comment...

Post has attachment
With only 33% of the study’s sites, Canada enrolled 55% of the patients and the study was closed to enrollment  three months ahead of schedule. See how they did it thanks to the Reverse Feasibility Program!
Add a comment...
Wait while more posts are being loaded